Aviva PLC Chroma Dex Corp. Transaction History
Aviva PLC
- $39.7 Billion
- Q1 2025
A detailed history of Aviva PLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Aviva PLC holds 53,055 shares of CDXC stock, worth $325,757. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,055Holding current value
$325,757% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CDXC
# of Institutions
149Shares Held
24.4MCall Options Held
190KPut Options Held
14.1K-
Vanguard Group Inc Valley Forge, PA3.54MShares$21.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$19.1 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA1.99MShares$12.2 Million6.26% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.28MShares$7.88 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.18MShares$7.24 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $420M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...